Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1a/b Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

NCT06641310 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT06641310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06641310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1a/b Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 13, 2026
Completion date
May 31, 2028
Enrollment
32 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

familial adenomatous polyposis